Cargando…

Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.

Detalles Bibliográficos
Autores principales: Gossner, L., Wittke, H., Warzecha, A., Sroka, R., Ernst, H., Meier, M., Ell, C.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977291/
https://www.ncbi.nlm.nih.gov/pubmed/1830212
_version_ 1782135230182719488
author Gossner, L.
Wittke, H.
Warzecha, A.
Sroka, R.
Ernst, H.
Meier, M.
Ell, C.
author_facet Gossner, L.
Wittke, H.
Warzecha, A.
Sroka, R.
Ernst, H.
Meier, M.
Ell, C.
author_sort Gossner, L.
collection PubMed
description
format Text
id pubmed-1977291
institution National Center for Biotechnology Information
language English
publishDate 1991
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19772912009-09-10 Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy. Gossner, L. Wittke, H. Warzecha, A. Sroka, R. Ernst, H. Meier, M. Ell, C. Br J Cancer Research Article Nature Publishing Group 1991-07 /pmc/articles/PMC1977291/ /pubmed/1830212 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Gossner, L.
Wittke, H.
Warzecha, A.
Sroka, R.
Ernst, H.
Meier, M.
Ell, C.
Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.
title Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.
title_full Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.
title_fullStr Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.
title_full_unstemmed Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.
title_short Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.
title_sort verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977291/
https://www.ncbi.nlm.nih.gov/pubmed/1830212
work_keys_str_mv AT gossnerl verapamilandhematoporphyrinderivativefortumourdestructionbyphotodynamictherapy
AT wittkeh verapamilandhematoporphyrinderivativefortumourdestructionbyphotodynamictherapy
AT warzechaa verapamilandhematoporphyrinderivativefortumourdestructionbyphotodynamictherapy
AT srokar verapamilandhematoporphyrinderivativefortumourdestructionbyphotodynamictherapy
AT ernsth verapamilandhematoporphyrinderivativefortumourdestructionbyphotodynamictherapy
AT meierm verapamilandhematoporphyrinderivativefortumourdestructionbyphotodynamictherapy
AT ellc verapamilandhematoporphyrinderivativefortumourdestructionbyphotodynamictherapy